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Recurrent successions of genomic changes, both within and between patients, reflect repeated evolutionary 
processes that are valuable for anticipating cancer progression. Multi-region sequencing allows the temporal 
order of some genomic changes to be inferred within a tumour, but the robust identification of repeated 
evolution across patients remains an unmet challenge. Here we present a machine learning method based on 
Transfer Learning that overcomes the stochastic effects of cancer evolution and noise in the data, and identifies 
hidden evolutionary patterns in cancer cohorts. When applied to multi-region sequencing datasets from lung, 
breast, renal and colorectal cancer (768 samples from 178 patients), our method detected repeated evolutionary 
trajectories in subgroups of patients, which reproduced in single-sample cohorts (n=2,935). Our method 
provides ways to classify patients based on how their tumour evolved, with implications for anticipating cancer 
evolution.   
Introduction 
 
The biggest challenge in oncology is the fact the tumours change over time, progressing from benign to 
malignant, becoming metastatic, and developing treatment resistance1,2. This occurs through a process of clonal 
evolution involving cancer cells and their microenvironment3, and results in intra-tumour heterogeneity (ITH). 
ITH contributes to the lethal outcome of cancer by providing the substrate of phenotypic variation upon which 
adaptation can occur4. A fundamental question is therefore: can we predict a cancer’s next evolutionary “step”? 
The question of predictability, first posed by Stephen Jay Gould for species evolution5, is also central in 
oncology.  
 
Clonal evolution results from the interplay of random mutations, genetic drift, and non-random selection6, 
leading to complex patterns in the data and limiting predictability due to stochastic forces7.  However, 
histopathological staging and molecular markers indicate that, at least in part, tumour evolution is predictable. 
Moreover, despite its stochastic nature, micro-environmental, epistatic, and lineage constraints may allow for a 
limited set of evolutionary steps after tumor sampling to be predicted2. Indeed, previous approaches based on 
single-sample cross-sectional data have revealed recurrent sequences of genomic events in cancer cohorts8-11. 
 
Recent studies have used multi-region sequencing, which allows the partial order of somatic aberrations in a 
tumour to be determined using phylogenetic analysis2. However, truncal (clonal) alterations cannot be ordered 
in most cases and phylogenetic trees from different patients often appear very distinct12-18. High levels of 
technical noise and biological variability currently prohibit the robust inference of repeated evolutionary 




Here we exploit the fact that tumours in different patients can represent multiple instances of the same 
evolutionary process. We devised REVOLVER (Repeated EVOLution in cancER), a method that jointly analyses 
multi-region sequencing data from patient cohorts by using a machine learning approach called Transfer 
Learning (TL)19. REVOLVER infers multiple patient evolutionary models jointly, with the aim of increasing their 
structural correlation. Our method exploits multiple independent noisy observations (i.e. single patients), and 
“transfers” information between patients to de-noise data and highlight hidden evolutionary patterns (Figure 1). 
The individual models still explain the data in each patient, while at the same time highlighting subgroups of 
tumours that evolved similarly.  
Results 
	
Approach and method description 
	
Multi-region sequencing allows ITH to be assessed in individual patients, with particular focus on recurrent 
driver alterations. To detect repeated evolutionary trajectories across patients (Fig. 1A), the classical approach is 
to reconstruct the phylogenetic tree of each tumour (Fig. 1B). However, standard tools determine one tree per 
patient at a time, meaning that each patient model is independent and models are uncorrelated. The stochasticity 
and complexity of the evolutionary process, inter-patient variability and technical noise render the statistical 
signal of repeated trajectories very weak (Figure 1C).  
 
A further complication is that multi-region bulk samples are cell population mixtures that require subclonal 
decomposition20. For each sample, measured allelic abundances must be transformed into the cancer cell 
fraction (CCF), the proportion of cancer cells carrying the mutation. However, strong tumour sampling bias 
confounds CCF estimates, making it difficult to infer the correct phylogenetic tree via the commonly used 
pigeonhole principle21. (The principle, which can distinguish linear and branched evolution, holds that if the 
CCF of two subpopulations sums to more than 1, then one subpopulation must be nested in the other; 
Supplementary Fig. 1.) Moreover, CCF estimation requires that sequencing data is corrected for purity, ploidy, 
absolute copy number, and mutation multiplicity (number of genomic copies carrying a mutation) for each 
variant used for phylogenetic reconstruction. This correction process propagates a significant amount of noise 
into the final CCF estimates and, consequently, in the associated phylogenetic trees. 
 
REVOLVER implements a Maximum Likelihood (ML) method to jointly fit n models from n datasets (D1, ..., Dn) 
for which either CCF or presence/absence annotations are available (Fig. 1D, Online Methods, Supplementary 
Note 1, Supplementary Software and https://github.com/caravagn/revolver). The method will process any 
alteration that can be annotated in these formats (e.g. mutation, copy number alteration, etc.). Each model is a 
tree that represents a partial ordering of the annotated alterations. To perform the fit, REVOLVER analyses a set of 
trees per patient (solutions) via a two-step Transfer Learning strategy that outputs n correlated evolutionary trees 
(T1, ..., Tn) (Supplementary Figs. 2 and 3). Possible solutions can be pre-computed with external phylogenetic 
tools22-27 and passed to REVOLVER, or can be directly computed within REVOLVER, for both CCF and binary data. 
The method requires a score per tree, which can be the model’s likelihood against data, e.g., 𝑝 𝐷 𝑇  for tree T, 
or any other suitable scalar that we seek to maximize. 
 
REVOLVER uses fits to measure the heterogeneity of the trajectories, and to calculate an evolutionary distance to 
compare patients and identify tumours shaped by similar trajectories (stratification, Fig. 1E). Overall confidence 
in the predictions can be assessed with a jackknife approach28 (Supplementary Note 2). 
 
Finally, the genomic features of the trajectories identified using a multi-region training dataset (training set) can 
be exploited to classify larger, single-sample cohorts (test sets). We note that annotations of genomic features 
(e.g. drivers) are left to the user in order to make REVOLVER applicable to different cohorts. 
 
Synthetic and biological validation 
 
We validated REVOLVER against synthetic data representing 1,620 cohorts, >86,000 patients and 200,000 
samples (Online Methods and Supplementary Note 3). In every test, we generated a number of random 
phylogenetic trees and simulated consistent CCF values from multi-region bulk profiling. True models were 
associated with repeated evolutionary trajectories, which we sought to retrieve with REVOLVER and standard 
uncorrelated phylogenetic inference. To introduce realistic allele sampling bias21, we simulated a fraction of 
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cases with equally likely solutions (ambiguous CCFs, Supplementary Fig. 1). We also added Gaussian noise to 
model uncertainty in CCF estimates (Fig. 2A). Standard approaches use CCF data from a single patient to rank a 
set of possible phylogenetic trees; however, due to the uncertainty described above, the true solution does not 
always rank at the top (Fig. 2B), confounding the detection of repeated trajectories. REVOLVER de-noises the 
data and resolves ambiguity by transferring information across trees. In the presence of sampling bias, with and 
without technical noise, we found that REVOLVER is better at identifying the true evolutionary model, even when 
a large proportion of tumours have ambiguous solutions (Fig. 2C; Supplementary Fig. 4). 
 
We next sought to validate REVOLVER against known evolutionary trajectories describing the well-studied 
adenoma-to-carcinoma transition in colorectal cancer29, which proceeds via a step-wise accumulation of 
genomic aberrations. A significant proportion of colorectal cancers develop from adenomas, as evidenced by the 
success of bowel cancer screening and polypectomy procedures worldwide30,31. We leveraged a recent multi-
region sequencing colorectal cancer dataset involving mutations in 9 adenomas and 10 carcinomas32 (95 total 
samples, median 5 per patient; Supplementary Table 1, Supplementary Fig. 5). The dataset recapitulates the 
transition, which involves known driver genes such as APC, KRAS, TP53 and PIK3CA, and the stage of disease, 
adenoma or carcinoma, was hidden to REVOLVER. The method identified multiple transitions between pairs of 
events that characterise key evolutionary trajectories (Fig. 2D). For instance, REVOLVER leveraged information 
from adenomas to detect trajectories that were hidden in carcinomas (truncal mutations). The complete 
APC→KRAS→PIK3CA trajectory was never explicitly observed in a single patient but became detectable when 
patients were jointly analysed with TL. These recovered trajectories demonstrate the ability of REVOLVER to 
identify repeated evolution from multi-region datasets, even in cases where noise and partial observations 
obscure the true trajectory in most patients. 
 
Recurrent trajectories in non-small cell lung cancer 
 
We applied REVOLVER to the TRACERx dataset, the largest multi-region profiling effort to date, currently 
comprising 𝑛 = 100 non-small cell lung cancers18 (Supplementary Table 2, Supplementary Note 4). In this 
cohort, each tumour underwent whole-exome sequencing (500x depth) of multiple spatially separated regions, 
and a set of putative driver mutations and focal copy number alterations were annotated (302 total samples, 
median 3 per patient; 65421 total alterations, 450 drivers). We analysed the CCF values for all available patients 
(𝑛 = 99) and used the alterations annotated in the original study. We considered recurrent drivers those 
appearing in at least 2 patients, and performed a gene level analysis (i.e. we do not consider where the mutation 
occurs within a gene) to maximise the number of recurrent alterations. Although hotspot-level analysis could be 
performed, larger cohorts are required to achieve a suitable level of recurrence and transfer information across 
patients. 
 
REVOLVER generated 𝑛 = 99 correlated models and identified several repeated evolutionary transitions that 
grouped into 10 clusters, C1-C10 (Fig. 3A; Supplementary Figs. 6, 7). A jackknife approach28 (Supplementary 
Note 4) confirmed cluster robustness, with 80% median cluster stability and strongest signal for C2, C3, C4, C6 
and C8 (Supplementary Fig. 8). Clusters C4 and C6 have slightly weaker separation across resamples, and lower 
support is observed for small clusters like C10, or for C1 which has no clear signature. Importantly however, 
individual evolutionary trajectories (e.g. CDKNA→TP53) were highly robust (Supplementary Note 4). Cluster C5 
describes the trajectory CDKNA→TP53→TERT (overall support >90%), suggesting progressive cell-cycle 
deregulation, anti-senescence, genomic instability and bypass of cell death (Fig. 3B). Two other clusters, C4 and 
C6, are associated with early EGFR alterations, with C4 also acquiring late TP53	loss. It is important to note that 
clustering the occurrences of driver alterations alone does not identify clear subgroups, even if one accounts for 
clonality status (Supplementary Fig. 9).  
 
Furthermore, a comparative analysis against approaches based on single-sample cross-sectional cohorts11, akin 
to refs8-10,33,34, demonstrates the additional power of REVOLVER predictions, which combine multi-region data, 
phylogenetic theory and TL (Supplementary Fig. 10). By transferring information across patients, REVOLVER 
can also retrieve the temporal ordering of events within the same node of a tree, that could not otherwise be 
ordered. This feature is called expansion, and it is illustrated for patient CRUK0016 (cluster C5) where we could 
identify the ordering in the trunk of the tree (Fig. 3C). We also note that the phylogenetic tree fit for CRUK0016	




Finally, repeated evolutionary trajectories extracted from multi-region sequencing data with REVOLVER can be 
used to derive a decision tree that classifies large single-sample cohorts. In this case, stratification of 𝑛 = 883 
single-sample tumours35-37 demonstrate that many of the REVOLVER subgroups show significant differences in 
disease-free survival (Supplementary Fig. 11). Notably, previous large-scale single sample studies did not find 
clinically relevant subgroups using standard approaches38. 
	
Recurrent trajectories in breast cancer 
 
We applied REVOLVER to a cohort of 𝑛 = 50 primary breast cancers where multi-region whole-genome and 
targeted deep sequencing was available15 (292 total samples, median 6 per patient; 403 total alterations, 296 
drivers; Supplementary Table 3, Supplementary Note 4). In each sample, a panel of mutations and CNAs 
(cytoband-level and whole-arm) in breast cancer putative driver genes were annotated15. For this study, we 
processed all annotated mutations and CNAs as presence/absence in a sample, and considered recurrent those in 
at least 2 patients. REVOLVER identified several repeated evolutionary transitions (Fig. 4A) that characterised 6 
evolutionary groups (Supplementary Figs. 12, 13). Again, the results were robust, but with slightly lower scores 
than those observed in the lung cohort possibly due to the lower resolution of binary data compared to CCF, 
which renders it more difficult to retrieve temporal orderings. However, the inferred trajectories were well 
supported by the data (Supplementary Fig. 14). For example, subgroup C2 described the repeated evolutionary 
trajectory TP53→PIK3CA→-8p→+8q	(Fig. 4B,C), identified with >90% support (Supplementary Note 4). Again, 
standard clustering based on the patterns of occurrences of driver alterations does not identify similar groups 
(Supplementary Fig. 15).  
	
We used repeated trajectories to create a decision tree (Fig. 5A) and stratify 𝑛 = 1,752 single-sample breast 
cancer cases from the METABRIC39,40 (𝑛 = 1,318) and BRCA TCGA41 (𝑛 = 434) studies. We found that our 
evolutionary subgroups replicated in these cohorts (Fig. 5B), and survival analysis highlighted significant 
differences between clusters (Fig. 5C).	Our evolutionary subgroups are enriched for specific breast cancer 
subtypes from the IntClust (based on both transcriptomic and copy number alterations) and PAM50 
(transcriptomics alone) classifications (Fig. 5D, 5E). Interestingly, REVOLVER group C3, which shows 
significantly poorer survival and is characterised by the evolutionary trajectory	TP53→+8, was enriched for 
IntClust 10 and basal subtypes. This analysis demonstrates how evolutionary groups identified with REVOLVER 
can be combined with cancer subtypes to inform how these tumours evolved. 
	
Recurrent trajectories in renal cancer 
	
We used REVOLVER to analyse somatic mutations in a cohort of 𝑛 = 10 clear cell renal cell carcinomas (79 
samples, median 8 per patient; 843 alterations, 75 drivers)12. We could identify repeated evolution involving 
mutations in PBRM1 and BAP1, well-known predictors of the evolution of this malignancy12, further validating 
the approach. The identified trajectories reproduced in single-sample cohorts and have prognostic significance, 




Detecting repeated evolution in cancer is critical for the implementation of evolutionary approaches to disease 
management. Stratifying patients based on their recurrent evolutionary patterns helps to predict future steps of 
malignant progression, thus potentially informing optimal and personalised clinical decisions.  
 
Although the application of machine learning to biomedical datasets is becoming popular43, the use of these 
methods as ‘black boxes’ to mine cancer genomic data is unlikely to be successful unless combined with clinical 
and biological knowledge. In particular, analysing results in light of the cancer evolution paradigm is essential. 
 
Our Transfer Learning approach combines high-quality multi-region sequencing data of driver alterations and 
phylogenetic theory to detect the hidden signal of repeated evolution within multiple tumour types. Approaches 
that attempt to compare uncorrelated evolutionary models or cluster alterations fail to identify repeated 
evolution between patients. Our approach also helps to reconcile multi-region sequencing data with large single-
sample cohorts by combining different data types and extracting more information on the evolutionary process 
from both strategies concurrently.  
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REVOLVER can be used with both binary and CCF values and can be employed in conjunction with any 
method providing multiple scored phylogenetic trees per patient. Importantly, our method is adaptable to a wide 
range of input data, making it readily usable for higher resolution datasets as they become available. Moreover, 
stratification power could further increase with larger datasets, and REVOLVER can be applied to single-cell 
sequencing data. The repeated evolutionary trajectories we identified were associated with subsets of patients 
with distinct prognosis, demonstrating the likely clinical value of stratifying patients based on how their 
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Figure 1. Identifying repeated evolution in cancer multi-region sequencing data using Transfer Learning. 
(A) Multi-region sampling (red circles) is used to characterise genomic intra-tumour heterogeneity (ITH). Some 
evolutionary trajectories are shared by patient subgroups with common somatic drivers (red or purple group) but 
remain hidden because of apparent variability in genomic patterns between patients. (B) The standard approach 
(top) is to infer one evolutionary model (ie, phylogenetic tree) per patient at a time, and then compare the 𝑛 
trees. Because models are inferred independently, statistical signal for repeated trajectories is weak and few are 
identified (only part of purple trajectory, bottom). (C) REVOLVER uses Transfer Learning (top) to infer 𝑛 models 
jointly and increase their structural correlation; 𝑛 trees explain the data in each patient while highlighting 
repeated evolutionary trajectories in the cohort (bottom).      
	
Figure 2. Synthetic test of the method and biological validation. (A) Testing with synthetic data simulating 
20 cohorts of 𝑛 = 50 patients with 1-3 bulk regions each (extended tests in Supplementary Fig. 4) and 
modelling sampling bias in 𝑝 = 10, 30, or 50% of patients, as well as Gaussian technical noise (𝜎 = 0.05). 
Compared to uncorrelated phylogenetic inference, REVOLVER retrieved more true trees (true positives), even for 
patients with ambiguous CCF data due to tumor sampling bias and noise. Boxplots show mean and inter quartile 
range (𝐼𝑄𝑅), upper whisker is 3rd quartile +1.5 ∗ 𝐼𝑄𝑅 and lower whisker is 1st quartile − 1.5 ∗ 𝐼𝑄𝑅. (B) 
Biological validation using a multi-region sequencing dataset of 𝑛 = 19 colorectal cancer patients (9 adenomas, 
and 10 carcinomas) covering the adenoma-to-carcinoma transition32. Alterations in key colorectal driver genes 
(rows) for every patient (columns) are shaded by the proportion of samples bearing the alteration; driver 
alterations are present/absent in a sample and truncal alterations are denoted by orange squares (lower heatmap). 
REVOLVER detected repeated trajectories (upper heatmap; e.g. APC→KRAS) which can be used to stratify patients 
(complete data in Supplementary Fig. 5).  Distance between patients is determined from the trajectories, which 
contribute proportionally to their frequency in the cohort; the dendrogram is then computed by hierarchical 
clustering (Ward’s method). REVOLVER trees (bottom) show that by transferring information across patients, 
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repeated evolution in early-stage tumours (adenomas) become informative of evolutionary trajectories in late-
stage tumours (carcinomas), in which many alterations appear clonal and cannot otherwise be ordered.  
 
 
Figure 3. Repeated evolutionary trajectories in lung cancer. (A) REVOLVER analysis of CCF data from 
𝑛 = 99 non-small cell lung cancers from the TRACERx study18 (columns are patients). Top heatmap shows the 
most recurrent evolutionary trajectories (complete data in Supplementary Fig. 6). Bottom heatmap shows 
average CCF values (provided in18) for the most recurrent putative driver genes. Alterations are ordered by 
frequency in the cohort, truncal alterations are denoted by orange squares. REVOLVER stratified this cohort by 
repeated evolution into 10 evolutionary subgroups (Supplementary Fig. 7). Subgroup stability was estimated via 
jackknife (𝑁 = 1,000 resamples, leave out 𝑝 = 10%; Supplementary Fig. 8) and annotated in the dendrogram 
(median per cluster). These groups can be used to derive a decision-tree classifier that stratifies 𝑛 = 589 
tumours in orthogonal single-sample cohorts (Supplementary Fig. 11). (B) Repeated trajectories in cluster C5. 
Arrows indicate transitions. Number of times a transition is observed among the 9 patients, number of times an 
alteration is clonal or subclonal in the cohort, and probability of detecting the edge across resamples are 
indicated (Supplementary Note 4). (C) Phylogenetic model for patient CRUK0016 (cluster C5) has 13 clones 
(CCFs clusters), 5 with drivers annotated (in colour). The REVOLVER tree ranked 5th of 56 possibilities. Via 
Transfer Learning, REVOLVER can also estimate the intra-clone orderings, for example the trajectory 
CDKNA→TP53→TERT can be expanded.  
	
Figure 4. Repeated evolutionary trajectories in breast cancer. (A) REVOLVER analysis of data from 𝑛 = 50 
breast cancers from Yates et al. 201515 (columns are patients). Top heatmap shows the most common repeated 
evolutionary trajectories identified by our method (complete data in Supplementary Fig. 12). Bottom heatmap 
shows average proportion of samples bearing the alteration (provided in15) for the most recurrent putative driver 
genes (data were presence/absence). Alterations are ordered by frequency in the cohort, truncal alterations are 
denoted by orange squares. REVOLVER stratified this cohort into 6 evolutionary subgroups (Supplementary Fig. 
13). Subgroup stability was estimated via jackknife (𝑁 = 1,000 resamples, leave out 𝑝 = 10%; Supplementary 
Fig. 14), and annotated in the dendrogram (median per cluster). (B) Repeated trajectories in cluster C2. Arrows 
indicate transitions. Number of times a transition is observed among the 11 patients, number of times an 
alteration is clonal or subclonal in the cohort, and probability of detecting the edge across resamples are 
indicated. This group highlights the evolutionary trajectory TP53→PIK3CA→-8p→+8q.	(C) The clone tree for 
patient PD14753 (cluster C2) had 11 nodes, 7 of which contain drivers (in colour). With a standard approach, 
this tree would have scored 2/200 alternative trees. By transferring information from other patients in the cohort 
(dashed lines), REVOLVER can expand evolutionary transitions within the same node. TP53 was identified as a 
tumour-initiating alteration (early clonal), followed by loss of 16q/17p (late clonal). Uncertainty on -16q and -
17p ordering remains because of equally likely observations in the cohort. Transfer Learning also works at 
subclonal level, identifying the trajectory FANCD2→BRCA2. The order of MLL3 and KDR remained uncertain.  
	
Figure 5. Stratifying single-sample cross-sectional cohorts with repeated evolutionary trajectories. (A) 
Subgroups identified with REVOLVER (from the multi-region breast cancer dataset in this example) can be used 
to build a decision tree. (B) The decision tree was used to classify 𝑛 = 1,752 single-samples tumours from large 
cross-sectional cohorts (METABRIC and TCGA BRCA2012), showing that REVOLVER subgroups reproduced in 
large orthogonal datasets. Most recurrent driver alterations, PAM50 and IntClust classifications are reported. 
(C) Evolutionary subgroups identified by REVOLVER were prognostic (two-tailed log-rank test, 𝑝 < 0.05, 95% 
confidence interval shaded). Interestingly, poor survival group C3 was enriched for a specific subset of basal 
tumours characterised by trajectory TP53→+8q (see Supplementary Fig. 11 for same analysis in lung cancer). 
(D, E) Enrichment of REVOLVER clusters for IntClust classification and PAM50 classifications (one-tailed 
Fisher’s Exact test, 𝑝 < 0.05 adjusted with Bonferroni correction, odds ratio and confidence interval in 
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The number of cancer evolution studies involving multi-region sequencing are rapidly growing (see, e.g., the 
case studies in12-15,17,18,44), and intra-tumour heterogeneity profiling allows reconstructing the spatio-temporal 
evolutionary history of a patient tumour2. 
 
REVOLVER	takes as input n multi-region sequencing datasets from n patients 𝐷!,… ,𝐷!. Each sample from a 
patient contains information on what genomic alterations are present in that specific sample. Our method is 
agnostic to the type of alteration annotated, which could be a nucleotide substitution (SNV), a copy number 
alteration (CNA) or any other (epi)genomic event. For each event, two data formats can be processed: 
 
• Cancer Cell Fractions (CCF), or the proportion of cancer cells in the sample that bear the alteration. 
• If CCF values are unavailable, a simpler binary format with presence/absence of the alteration in a sample. 
 
The method also requires to specify for every patient when sets of alterations occur together in the same clone: 
 
• For CCF data, clones are estimated via subclonal reconstruction (i.e., CCF-based clustering); 
• For binary data, alterations are assumed to be in the same clone if found in the same set of samples. 
  
For each genomic alteration, the input should also clarify if it is a putative driver, and/or truncal (i.e., present in 
100% of cancer cells, or in the case of binary format, present in all samples; see Supplementary Note 1 for 
details on the input format).  
 
In REVOLVER, we call alterations that are detected in multiple patients recurrent. We will use a parameter to 
determine a minimum recurrence threshold. 
 
Evolutionary trajectories using a standard approach  
 
For each patient, we can construct an evolutionary model (e.g. a phylogenetic tree) that explains the data via a 
standard approach such as those presented in refs12-15,17,18,44.  In what follows, we will seek to compare our 
method to the principles underpinning those approaches. 
 
For a cohort of n patients, we would identify n evolutionary models 𝑇!,… ,𝑇! where:  
 
• Each 𝑇! is a tree describing the evolutionary history of a patient’s tumour. Its nodes are the groups of input 
alterations. In the case of CCF data this is a clone tree and each node is a clone, whereas in the case of 
binary data this is a mutation tree45. The tree encodes the (partial) temporal ordering of the alterations in the 
tumour.   
• An evolutionary trajectory is defined as a path 𝑥! → 𝑥! → ⋯  that connects alterations 𝑥!, and describes 
their order of accumulation: 𝑥! is earlier than 𝑥!, 𝑥!, etc, while 𝑥! is earlier than 𝑥!, 𝑥! etc. It can be 
computed from the ordering of the nodes in a tree.  
 
Ideally, in order to interpret the data from a whole cohort of patients in light of tumour evolution, one would 
like to identify recurrent evolutionary trajectories describing repeated evolution across patients. Repeated 
evolution in cancer describes recurrent sequences of events that fundamentally underpin tumorigenesis and 
progression in a given subgroup of patients. Repeated evolutionary trajectories pinpoint evolutionary “steps” of 
a tumour, and could underlie advantageous phenotypic changes to the cancer clone.  
 
Therefore, one needs a method that identifies trajectories that 1) are repeated across the cohort, and (hence) 2) 
involve recurrent alterations (drivers). Specifically, we need a method that correlates a trajectory involving 
recurrent drivers x and y, present within a sequence that may include passengers 𝑝!: 
 
… → 𝑥 → 𝑝! → ⋯ → 𝑝! → y → ⋯ 
 
See Supplementary Figure 2.  
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Using a standard approach based on phylogenetic theory, such as Maximum Parsimony46 or Maximum 
Likelihood27, one would infer each phylogenetic model 𝑇! independently for each patient. A Bayesian approach 
would compute independently n posteriors 𝑝 𝑇! 𝐷!  for i=1,.., n, and use them to sample models with high 
likelihood.  
 
With n independent models, we could evaluate post hoc structural similarities between patients. However, visual 
inspection of a set of phylogenetic trees is impractical with complex models or large n. Automatic approaches 
that use structural distances, or that measure similarities among the distributions induced by these probabilistic 
models, can help. Nevertheless, this approach to the detection of repeated evolutionary trajectories remains 
impractical because cancer multi-region cohorts exhibit a high degree of heterogeneity both between and within 
patients (see ref1,2 for a review), as well as inherent noise in the data.  
 
Evolutionary trajectories using Transfer Learning 
 
We propose a new approach to detect repeated evolutionary trajectories from noisy multi-region sequencing 
data of cancer patients. We assume that the recurrent trajectories can be modelled as a tree, which is hidden in 
the data. To capture heterogeneity across patients, we consider each input tumour as a noisy realisation from 
such tree (a realisation being the evolutionary trajectories for a patient, and its associated dataset).  
 
In probabilistic terms, the individual patient trees are coupled through a shared prior, so that the (marginal) 
posterior distribution of patient trees no longer factorises across patients. Consider a joint posterior over 
𝑇!,… ,𝑇!; we expect the solutions to differ in the following statistical sense  
 





In practice, a joint inference correlates explicitly n models of evolutionary processes: the solutions will be 
statistically dependent, and hence correlated across patients.  
 
We argue that the detection of statistically significant regularities from correlated models is a better approach to 
exploit data of n (independent) evolutionary processes that describe the same tumour. Synthetic tests show that 
this method improves over standard uncorrelated methods, particularly in the presence of sampling bias and 
technical noise in CCF. 
 
The REVOLVER algorithm 
 
In REVOLVER	--	Repeated evolution in cancer	--	we adopt an Expectation Maximisation (EM) strategy for 
Maximum Likelihood (ML) estimation of the n trees (Supplementary Note 1). The structural correlation among 
each model is measured via a parameter w, which we maximise. From w, we estimate repeated evolution of the 
n input tumours, and induce a distance metric for cohort stratification. 
 
First, REVOLVER	processes input data and group (clone) assignments to pre-compute a set of scored trees for 
every patient. This is done differently depending on whether CCF or binary data is available and can be 
modified to accommodate custom tree learning methodologies (see below). 
 
Then, a two-steps Transfer Learning (TL) strategy computes the joint ML estimates of 𝑇!,… ,𝑇!. Very broadly, 
TL is a Machine Learning paradigm to exploit knowledge gained while solving multiple related tasks. Here, the 
inference of the model for a patient (one task) becomes informative for the inference of other models (other 
tasks)19. The features shared among correlated tasks are recurrent drivers and their evolutionary trajectories (i.e., 
orderings). We remark that TL is sometimes used to indicate a broader class of problems; in the Machine 
Learning literature, our approach could be more specifically called multi-task learning. 
 
Precisely, REVOLVER	does the following steps (Supplementary Figures 2, 3): 
 
• computes n correlated models 𝑇!,… ,𝑇!, from the ones available for each patient; 
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• computes the evolutionary trajectories within each group of alterations annotated in every patient and 
refines fit estimates accordingly. These trajectories cannot be detected unless we analyse data from multiple 
patients, and we “transfer” trajectories across inference tasks. 
 
REVOLVER	is a model-selection strategy. We first discuss how it computes correlated models, and then how its 
input models can be computed from CCF or binary data. 
 
Correlating evolutionary trajectories across patients 
 
A dataset 𝐷!  of a single patient is a matrix with alterations as columns, and samples sequenced from the i-th 
patient as rows. With input CCF, each entry of 𝐷! is a real value in [0,1]; with binary data 1s report where the 
alteration is detected. We assume that 𝐷! has no 0 columns and denote as {𝐷!|𝑖 = 1, . . , 𝑛} the data from the 
whole cohort. 𝑉 =  𝑉!!!!!  is the whole set of alterations in the cohort;  𝑉!  the ones that occur in the i-th patient.  
 
Evolutionary trajectories from groups (Supplementary Figure 2).  Consider a driver x, and denote with 𝑘! 
the number of patients where it occurs; define  
 
Γ = 𝑥 ∈ 𝑉 𝑘! ≥ 𝜃 ∪ {⋆} 
 
the set of recurrent alterations that occur in at least 𝜃 > 1 patients, plus a special symbol ⋆ that stands for 
“germline” ancestor. REVOLVER	processes the whole dataset and induces correlation among drivers in Γ.   
 
We write 𝑥⟶ 𝑦 ∈ 𝑇 for an edge appearing in a tree T and introduce a special definition of the transitive 
closure of ⟶, usually denoted as ⟶∗ (Supplementary Figure 2,3). In general, the transitive closure of a 
path 𝑥⟶ 𝑦⟶ 𝑧 is the set of edges ⟶∗= {𝑥⟶ 𝑦, 𝑦⟶ 𝑧, 𝑥⟶ 𝑧}; 𝑥⟶ 𝑧 follows by ⟶’s closure. In this 
work, we have a special interest for evolutionary trajectories among recurrent drivers. Consider for the i-th 
patient the trajectory 
 
𝑝′! ⟶ ⋯⟶ 𝑝!! ⟶ 𝑥⟶ 𝑝! ⟶ ⋯⟶ 𝑝! ⟶ 𝑦⟶ ⋯     where  𝑝! , 𝑝′! ∉ Γ  and 𝑥, 𝑦 ∈ Γ 
  
We write 𝜋!! = 𝑥 to denote the recurrent driver upstream of y in this patient; these trajectories are correlated in 
REVOLVER. We indicate them by the notation 𝜋!! = 𝑥⟶∗ 𝑦, or when it is clear by 𝑥⟶∗ 𝑦. 
 
Because input alterations are grouped into clones, we need to account for groups when we create trajectories. If 
𝑔! ⟶ 𝑔! are two groups in a model’s path, and 𝑥! and 𝑦! are the driver alterations in those groups, we account 
for all combinations of orderings in the two groups with the trajectories 
 






This creates a combinatorial number of trajectories according to the number of drivers annotated in each group 
of a patient’s alterations. Clearly, the trajectory within a patient’s group is a linear ordering of its alterations 
that, however, cannot be estimated from a single patient. This is a confounding factor that renders the inference 
harder. However, by leveraging cross-sectional data from multiple patients diagnosed at different evolutionary 
times, one can recovery such trajectories and average out the confounders.  
 
Multinomial counts of trajectories. To measure the structural correlation among the models, we count how 
often they contain a path that connects x and y in Γ; the minimum among 𝑘! and 𝑘! is an upper bound to this 
count. 
 
Definition (Multinomial consensus) Given n trees 𝑇!,… ,𝑇!, we define the |Γ|× |Γ| discrete-valued consensus 
matrix w with entries 
 
𝒘!,! = | 𝑇!  | 𝑥⟶∗ 𝑦 ∈ 𝑇!; 𝑥, 𝑦 ∈ Γ | 
 
where 𝑥⟶∗ 𝑦 is a trajectory defined as explained above (Supplementary Figure 3). 
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Clearly, 𝒘!,!/𝑘! is an empirical probability for the observation of x upstream y in the n models. By 
construction, we are detecting a statistical signal among x and y, recurrent driver alterations that intertwine with 
passengers. The role of ⋆ is to capture which 𝑥 ∈ Γ is earliest in the trunk of a model (the associated trajectory is 
⋆⟶∗ 𝑥); so 𝒘⋆,! counts how many tumours are predicted to initiate via x. It must follow by tree construction 
that no alteration is upstream ⋆, and hence 𝒘!,⋆ = 0. 
 
Model-selection via Transfer Learning. REVOLVER requires a pre-computed set of trees per patient, and their 
scores (that must be sortable values); the algorithm uses those sets of models and 𝒘 as estimator of their 
structural correlation and selects each patient’s most correlated tree. Procedures to create trees are implemented 
in the framework, according to the input data; see Supplementary Note 1, for the algorithms’ pseudocode. 
 
REVOLVER’s score of a model 𝑇! is a rescaling of its pre-computed score by a factor that measures its structural 
deviation from the models of the other patients. The pre-computed score acts as a log-likelihood of the data 
under the model: 𝑝 𝑇! 𝐷! . 
 
Definition (Model's score) Let 𝛤! = 𝑉!⋂𝛤 be the recurrent drivers in patient i. A model 𝑇! for this patient has 
score 
 
𝑓!! = log 𝑝 𝑇! 𝐷! + log 𝑝 𝑇! 𝒘
! 
 
for 𝛼 ≥ 1. The latter term is a regularization term 
 
𝑝 𝑇! 𝒘 = 1 −




If the pre-computed scores factorize over models' edges, we can decompose the score as 
 




where 𝑝 𝑦 𝑥;𝐷!  are the edge terms obtained by fitting the tree’s parameters to 𝐷!. This factorization is 
common but is not a requirement. Technically, 𝑓!! is a penalised log-likelihood; we refer to 1 − 𝑝 𝑇! 𝒘  as the 
penalty that re-scales 𝑇!’s likelihood at polynomial rate with degree 𝛼. This overall quantity is the “information 
transfer” (Supplementary Figure 2); 𝛼 is a scaling factor that “shrinks” the penalty effect; in practice we always 
set it to 1 but it could be easily used to induce a stronger effect of the information transfer in shaping the 
gradient. In Supplementary Note 2, we show power calculations for the minimum information transfer to induce 
an ordering's swap. 
 
We observe the following properties of the above definition: 
I. the information transfer considers only penalties by predictions that disagree with 𝑇!. In fact, for any 
𝜋!! ⟶∗ 𝑥 in 𝑇!, term 𝒘!!! ,!  is subtracted from the penalty; 
II. we penalise independently each recurrent driver 𝑥 ∈  𝛤!, proportionally to the consensus of its 
evolutionary trajectories  𝒘!,!!  across the cohort; 
III. ⋆ does not have incoming edges; only its outgoing edges contribute to 𝑝 𝑇! 𝒘 . 
 
Definition (Model selection) To select n models 𝐓∗ = [𝑇!,… ,𝑇!], we solve a problem of discrete optimisation  
 
𝐓∗ = arg max 𝑻![!!,…,!!] [ 𝑓!! ,… , 𝑓!!] 
 
This problem is approached with an EM procedure. Because the trees are pre-computed for each model, a global 
solution for each initial EM condition is guaranteed. Given an initial estimate of the trees, 𝐓(!) we compute 𝒘(!) 
to select the 𝐓(!) that maximise REVOLVER’s score under 𝒘(!). We then iterate by estimating 𝒘(!)from 𝐓(!), 
etc.; we stop when we reach a fix-point 𝐓(!!!) = 𝐓(!) for some i, which is the ML estimate of 𝐓∗. 
 
Precisely, the E and M steps are (Supplementary Figure 3): 
• [E-step] from the current estimates of [𝑇!,… ,𝑇!], compute w; 
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• [M-step] use w to compute the penalty; for every patient update the scores of its pre-computed models, and 
determine the highest scoring (ML estimate). 
 
The ML estimates push to minimise the penalties in the sense that the optimisation gradient pushes 𝑝 𝑇! 𝒘  to 
1. In fact, with penalty 1 all the models predict the same trajectories for the variables in 𝛤, and we reach the 
objective of maximising the number of models, out of 𝑘!, that predict the same driver upstream x. To start this 
EM, one can sample multiple random initial conditions, and select the solution with lowest penalty; this can be 
done in parallel. Equivalence classes of solutions with the same score and penalty might exist; this depends on 
the distribution of the input pre-computed scores. The method, however, is more powerful than its un-correlated 
counterpart in estimating the true model, as we measured via synthetic tests. 
 
Computing trajectories within groups (expansion) 
 
We know that, in every model 𝑇!, we cannot compute trajectories for the alterations 𝑥!,… , 𝑥! that map to the 
same group g (e.g., those in the same clone). However, their trajectories might be detectable in those patients 
𝑇! ≠ 𝑇! whose alterations overlap with g, if they are sampled at an earlier time. Because the hidden model is 
assumed to be the same tree for all patients, 𝑇!’s trajectories are representative of the ones hidden in 𝑇! . 
 
In a TL approach, we transfer this information to 𝑇! and split g accordingly; we can do that once the first EM 
strategy has converged. We call this procedure “expansion” of a group (Supplementary Figure 3). This heuristic 
first subsets the entries of 𝑥!,… , 𝑥! from w, and then selects, for each 𝑥!, the most frequent parent driver. This is 
the multinomial ML estimate in w; if this does not exist because there is no evidence of any of the drivers in 𝑔 
to be upstream 𝑥!, then 𝑥! cannot be ordered and will be associated to the node upstream g. Ideally, if the input 
tumours were homogenous and we add observations from patients at different steps of progression, we could 
retrieve the unknown linear ordering (i.e., a topological sort) of 𝑥!,… , 𝑥!. In realistic cases, because of the 
uncertainty in the estimation of these trajectories and drivers’ annotation, we expect the expansion to be a graph 
that, of course, does not represent branched evolution. 
 
Notice that the expansion does not change 𝑇!’s original likelihood (since its data was uninformative of g's 
trajectories), but it still changes the tree structure, and hence w and the penalty. We expect expansion to reduce 
the variance of w; if the cohort were truly homogenous, the penalty should decrease as well since we are 
selecting one particular ordering of 𝑥!,… , 𝑥! from a homogenous cohort.   
 
Building input models from CCFs 
 
Consider a patient with c groups – in what follows called clones for consistency with CCF-based studies – from 
r sequencing samples, its CCF data is stored in a 𝑐× 𝑟 real-valued a matrix M. Each entry is a value in [0, 1], 
estimated from read counts, the input clone assignments of each alteration, copy number segments and tumour 
purity. REVOLVER’s implementation provides a method to compute phylogenetic trees to use as input for the 
tool. The tool allows one to input also a custom set of trees and scores. See also Supplementary Note 2. 
 
Generating trees. The method implemented exploits a modified version of ClonEvol, a tool for phylogenetic 
inference from CCF clusters47. This tool first enumerates, independently for each sample, all trees compatible 
with M and rooted in z, the truncal clone. Then, it tries to build a “consensus” tree model that fits all the r 
regions at once. To build a tree, ClonEvol uses the standard pigeonhole principle21: for a node x to branch 
towards 𝑦!,… , 𝑦!, the parent's CCF must be greater than the sum of 𝑦!’s CCF, that is 
  
𝐜𝐜𝐟 x > 𝐜𝐜𝐟(𝑦!)!!!! . 
 
Clearly, certain combinations of CCF values are ambiguous, and support alternative trees. For instance, if x has 
CCF 1 and y and z 0.3 and 0.1, then both the linear path 𝑥 → 𝑦 → 𝑧, and the branched model (x towards y and z) 
are plausible under the pigeonhole principle. Because of noise in CCF estimation and tumour sampling bias, a 
consensus model might only be available if we allow for violations of such principle.  
 
Ranking phylogenetic trees. We are not interested in a perfect consensus model, but rather we want to generate 
several alternative trees to input to REVOLVER. We modified ClonEvol to skip its last step and return the trees 
computed per region. With that, we could create a distribution of trees plausible under the input CCF, with a 
probability mass proportional to the extent to which a tree violates the pigeonhole principle under M, and the 
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empirical evidence of each edge (obtained from ClonEvol estimates). This ensures that, even without perfect 
CCF, we can still compute a model for the data, and quantify its goodness of fit, without sub-setting input. 
 
We proceeded as follows. Consider C, the set of clones annotated in M, and merge all trees into a weighted 
direct acyclic graph D whose nodes are C, and the weights are the average frequency of detection of the edges 
in each region, as estimated in ClonEvol. For each edge 𝑥 → 𝑦, this is the empirical probability 𝜆!,! of clone x 
to be a direct parent of y in the phylogenetic trees, according to the trees estimated by ClonEvol. Thus, D is a 
generator of the distribution of phylogenetic trees for data M, assuming all edges to be independent. 
 
The support of this distribution is the set of all minimum-spanning trees rooted in the truncal clone, which is 
known. This can be generated exhaustively only for small number of clone c = |C|, i.e., for a few thousand trees. 
If this is not the case, we can Monte Carlo sample a desired number of distinct trees for this patient; for each 
node y, its parents are sampled from the discrete marginal distribution 𝝀! = {𝜆!,!}. This exploits a factorization 
of the distribution over the tree’s nodes and leads to sample trees that maximize the observed frequencies of 
edges, as we might desire. 
 
Definition (Phylogenetic score) For a set of phylogenetic trees 𝒯, each 𝑇 ∈ 𝒯 can be scored as  
 










         
. 
where 𝟏𝒄𝒄𝒇 is an indicator function that evaluates to 1 if x satisfies the pigeonhole principle in the i-th region, 
and 0 otherwise.  
 
This score has the following desirable properties: 
• 𝜂 𝑇  and 𝜖 𝑥  span in [0,1], and allow for equivalent-scoring models; 
• 𝜖 𝑥  is a goodness-of-fit measure: lower values indicate increasing violations of the principle, for x in 
T, under data M. 
• terms 𝜆!,! is a probability that measures how often ClonEvol predicts x upstream of y; when this 
approaches 1 we have stronger evidence that x is upstream of y. 
• 𝜂 𝑇 = 1 only when 1) there is a unique possible assignment to the parents of every clone, and 2) there 
are no violations of the pigeonhole principle. 
 
This score 𝜂 𝑇  is a joint likelihood: the probability of each parent of a clone is weighted by a multinomial 
likelihood of error 𝜖 𝑥  estimated from the tumour data. This part of the algorithm can accommodate several 
customizations, and it is straightforward to use phylogenetic tools that provide alternative scoring function22-27.  
 
For our score or variations thereof, the following min/max interpretation holds. If we maximize 𝜂 𝑇  alone we 
select the tree with most-frequent structure (max), and the smallest violations (min). When 𝜂 𝑇  is combined 
within REVOLVER we expect a min/max-max shrinkage effect where, at the same time, we minimize errors in 
each phylogeny, and maximize both tree edges that are frequent and represent repeated evolution in the cohort.  
 
Building input models from binary observations 
 
Binary data is lower-resolution than CCFs but can still be used to create a mutation tree for a patient. To do that, 
REVOLVER implements a method that links Suppes' theory of probabilistic causation to cancer progression11,48,49.   
 
Definition (Suppes' probabilistic causation in cancer) For any two variables x and y, edge 𝑥⟶ 𝑦 can exist in 
Suppes’ probabilistic model only if 𝑝 𝑥 ≥ 𝑝(𝑦) and 𝑝 𝑦|𝑥 ≥ 𝑝(𝑦|¬𝑥), where 𝑝(∙) are empirical multinomial 
probabilities estimated via ML from binary data.  
 
A Suppes' partially ordered set (poset) Π! is the set of edges that satisfy probabilistic causation. We estimate for 
patient i its poset by data D!, and use it as building blocks of our mutation trees. Temporal priority acts as both 
an infinite sites assumption, and a no back-mutations model (in phylogenetic jargon). In practice, we are 
assuming that alterations are persistent and, accordingly, we estimate temporal precedence via marginal 
frequencies. Probability rising, instead, is a measure of the degree of association between two variables, which 
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implies statistical dependence as it is symmetric (like correlation), see Supplementary Note 2 for further 
discussion. 
 
A poset is also a weighted directed graph with constant normalized weights, if we assume all poset’s parents 
equally likely. So, it can be used to generate all minimum spanning trees rooted in the clonal group, which is the 
one whose alterations appear in all samples. Mutation trees can be sampled as done for phylogenetic trees, either 
exhaustively or by Monte Carlo, and can be scored via standard information theory. Each such model is a well-
known Chow-Liu tree, a generator of the joint distribution 𝑝(𝑐!,… , 𝑐!) if 𝑐!,… , 𝑐! are the w groups for this 
patient – i.e., the probability of observing the presence/ absence of the corresponding alterations in a sample50. A 
Chow-Liu tree contains second-order terms 𝑝 𝑦 𝑥  for the product approximation of the joint distribution that 
we factorise. It is well known that it has the minimum Kullback-Leibler divergence to the true distribution, 
being its closest approximation in an information-theoretic sense. 
 
Definition (Binary tree score) For a set of Chow-Liu trees 𝒯, each 𝑇 ∈ 𝒯 can be scored as  
 
𝜏 𝑇 = 𝐦𝐮𝐭𝐢𝐧𝐟 𝑥, 𝑦
!→! ∈ !
      
. 






    . 
 
Thus, the highest-scoring Chow-Liu tree is the optimal solution to this model-selection task. REVOLVER’s input 
Chow-Liu trees can be ordered by decreasing mutual information; our method will fit lower-rank ones only if 
they have smaller penalty.  
 
Synthetic tests  
 
We carried out synthetic tests with CCF data to validate and assess the performance of REVOLVER under 
different configurations of cohort size, number of samples per patient and other covariates modelling 
confounding factors. Tests and results are detailed in Supplementary Note 3 and Supplementary Figure 4. 
 
In a first batch of tests, we generated phylogenetic trees and CCF data under a combined model of tumour 
sampling bias. Statistically speaking, in some patients CCF will be hard to process (i.e., noisy): they will 
suggest linear and branched models of evolution with the same score. In other patients, CCF data will top-score 
the true evolutionary model.  Results show that REVOLVER, by transferring information across patients, can 
retrieve the true model also for patients with noisy CCF data. Uncorrelated inference (the baseline method that 
we compare against), instead, suffers from sampling bias and uncertainty in tree estimation. This shows that 
joint ML estimation of the correlated trees can de-noise genomics data, improving on the uncorrelated 
counterpart. 
 
In a second batch of tests, we investigated resistance to noise of our estimator. REVOLVER’s information transfer 
is estimated from data, thus if CCF data are dominated by noise, the algorithm will transfer “noise” and might 
fit repeated errors. We investigate this phenomenon with synthetic datasets affected by different intensities of 
Gaussian noise (technical noise) and show that REVOLVER is robust for reasonable ranges of those parameters. 
 
Further material and case studies  
 
REVOLVER is a framework with other features beyond its main inferential algorithm.  
 
In Supplementary Note 2 and 4 we present: 
 
I. Power calculations to correlate evolutionary trajectories; 
II. A scalar index of divergent evolution that measures the heterogeneity of the trajectories inferred; 
III. A REVOLVER-derived evolutionary distance (grounded in ecological theory for species’ diversity) to 
stratify the cohort into subgroups of tumours that harbour similar evolutionary trajectories. 
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IV. A jackknife approach to estimate the stability of clusters and trajectories. 
V. Further commentary on the approach; 
VI. Algorithmic settings for the analysis of real data. 
 
Data availability  
 
REVOLVER is available as an open source R tool at	https://github.com/caravagn/revolver	– a copy of the source 
code is available enclosed with this manuscript. The datasets used in our analyses have been downloaded from 
the corresponding publications, and are also available alongside the tool. The source code to replicate all our 
analyses is available in the form of RMarkdown vignettes available at the tool’s webpage. 
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